Resources
Download our recent poster presentations to see the impact of Retrogenix’s target deconvolution, receptor identification and off-target screening work.
Screening the secretome for off-target binding
As secreted proteins are not naturally localised on the cell surface, novel constructs which result in expression of ‘secreted’ proteins that are tethered to the plasma membrane have been developed and tested. Extensive validation work confirmed proof of principle and led to the development of the ‘high confidence’ library of secreted proteins now included in cell microarray screening….
Confirm target specificity/ uncover off-targets
This poster presents data from two off-target screens showing how the Retrogenix approach rapidly identifies specific and relevant off-targets with a very low rate of false positive results. The first study demonstrates target specificity and the second uncovers a previously unidentified, critical off-target…
CAR T cell specificity screening poster
Download our SOT 2017 poster describing the how the Retrogenix human cell microarray technology has been optimised to screen whole CAR T cells for specific interactions, reducing the risk of unanticipated off-target adverse effects in the development of novel immunotherapies and providing essential supporting data for pre-IND safety assessment.
Immune checkpoint poster
Download a recent poster presented at PEGS Boston to see some typical results from a cell microarray screen and learn how the Retrogenix technology can assist with immune checkpoint pairing.
Further examples of the applications of the cell microarray technology can also be found in the case studies resource on this website.
Antibody off-target screening poster
Biologics such as antibodies are widely favoured in drug discovery due to their inherent potential for specificity to a single target antigen. Despite this, off-target mediated toxicity could present an issue for a subset of antibodies and other molecules in development. Download our PEGS 2017 poster to learn how the Retrogenix human cell microarray technology approach is being applied to identify specific and relevant off-targets with a very low rate of false positive results.
Watch our animation
Retrogenix expresses thousands of full-length human proteins in the context of human cells in order to detect relevant interactions with test molecules.
The animation on this website provides an overview of how we set up the cell microarrays and use the technology to identify primary receptors targets and off-targets for a wide variety of ligands.
We were impressed with the power of the Retrogenix technology in terms of on/off target characterization of early drug candidates. Their quick turnaround time and excellent, proactive communication was a real pleasure.
Dr. Bernd Schlereth, Senior Director Nonclinical Safety, Covagen
Retrogenix.com uses cookies to function and to help us understand how to improve your user experience. To find out more about our use of cookies and your options, please click here.
Visit our Privacy Policy to learn more about how we store and handle data, and your privacy rights.
Visit our Privacy Policy to learn more about how we store and handle data, and your privacy rights.